Overview of Gefitinib in Non-small Cell Lung Cancer: An Asian Perspective
Author:
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Link
http://academic.oup.com/jjco/article-pdf/39/3/137/5102828/hyn139.pdf
Reference88 articles.
1. Global Cancer Statistics, 2002
2. Epidermal growth factor-related peptides and their receptors in human malignancies
3. A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design and synthesis of BMH-21-like quinazolinone derivatives as potential anti-cancer agents;Journal of Molecular Structure;2024-07
2. Efficacy and safety of EGFR inhibitor gefitinib in recurrent or metastatic cervical cancer: a preliminary report;Medical Oncology;2023-06-13
3. Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations;Proteomes;2023-02-05
4. Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3): a multicentre, randomised, double-blind, placebo-controlled trial;The Lancet;2023-02
5. Phase 1 study of DS‐1205c combined with gefitinib for EGFR mutation‐positive non‐small cell lung cancer;Cancer Medicine;2023-01-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3